HCID 21101726, compound → HCID 21101723, compound
Reaction equation
[Cl:1][C:2]1[CH:11]=[C:10]2[C:5]([C:6]([N:12]3[CH2:17][CH2:16][N:15]([C:18]([NH:20][CH:21]4[CH2:27][CH2:26][CH2:25][CH2:24][C:23](=[O:28])[CH2:22]4)=[O:19])[CH2:14][CH2:13]3)=[CH:7][CH:8]=[N:9]2)=[CH:4][CH:3]=1.[CH3:29][Mg+].[Br-]>C1COCC1>[Cl:1][C:2]1[CH:11]=[C:10]2[C:5]([C:6]([N:12]3[CH2:17][CH2:16][N:15]([C:18]([NH:20][CH:21]4[CH2:27][CH2:26][CH2:25][CH2:24][C:23]([OH:28])([CH3:29])[CH2:22]4)=[O:19])[CH2:14][CH2:13]3)=[CH:7][CH:8]=[N:9]2)=[CH:4][CH:3]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a stirred solution of 4-(7-chloro-4-quinolinyl)-N-(3-oxocycloheptyl)-1-piperazinecarboxamide (8 mg, 0.02 mmol) in THF (3 mL) was added a solution of MeMgBr (3M, 0.1 mL) at 0° C. After 5 h at 0° C., the reaction mixture was quenched with MeOH and Na2CO3 (sat. 50 mL). The reaction mixture was extracted with CH2Cl2, washed with brine, and dried over Na2SO4. Concentration in vacuo followed by preparative TLC gave the title product. LC-MS: 401 (M++1). 1H NMR (CDCl3) δ 8.78 (d, 1H), 8.05 (s, 1H), 7.95 (d, 1H), 7.45 (m, 1H), 6.85 (d, 1H), 5.75 (d, 1H), 4.45 (d, 1H), 4.05 (m, 1H), 3.65 (m, 4H), 3.20 (m, 4H), 1.55–1.95 (m, 10H), 1.35 (s, 3H).
Workup
- customthe reaction mixture was quenched with MeOH and Na2CO3 (sat. 50 mL)
- extractionThe reaction mixture was extracted with CH2Cl2
- washwashed with brine
- dry with materialdried over Na2SO4
- concentrationConcentration in vacuo
Sources & evidence
- ORD record
- ord-c012c654fef240dfbd29979e283c9e29
- Source dataset
- uspto-grants-2007_05
- Patent number
- US07220856B2
Reaction notes
Loading…